AI-Developed Rentosertib Shows Potential to Lower Biological Age in Clinical Trial
- Published
- Source
- AIInsider
An AI-designed drug, rentosertib, demonstrated changes in proteins linked to lower biological age in a 12-week phase 2a clinical trial for idiopathic pulmonary fibrosis (IPF). Six machine-learning aging clocks indicated biological-age reductions among participants, particularly with a 30-milligram twice-daily dosage.
This finding is significant as it suggests that AI-discovered medicines may have effects beyond their primary treatment targets. While the trial involved only 42 participants and could not definitively separate the drug's anti-fibrotic effects from potential anti-aging benefits, it highlights the innovative use of AI in drug development, particularly in assessing broader impacts during clinical trials.
Looking ahead, researchers emphasize the need for larger studies to further explore the drug's effects on aging processes. The study advocates for dual-purpose clinical trial designs that measure both disease-specific outcomes and aging-related endpoints, paving the way for more comprehensive evaluations of new therapies.
Original report
AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study
AIInsider · Matt SwayneThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
Preferred Networks
Tokyo deep learning company founded 2014; develops MN-Core AI chips, PLaMo LLMs, Kachaka AMR, and physical AI solutions for robotics and manufacturing.
AAtek Robo Private Limited
Coimbatore, India authorized DENSO Robotics distributor and system integrator offering industrial automation, lab automation, and Industry 4.0 solutions.
Drone4Agro Ltd
Voorthuizen, Netherlands start-up building CE-marked custom agricultural drones with 15-80 L tanks and 3-9 m spray spans for spraying and sowing.
Ben-Gurion University of the Negev
Israeli research university in Beer-Sheva operating the ABC Robotics Initiative covering agricultural, biological, and cognitive robotics research.
NextStep Robotics
Baltimore-based startup developing AMBLE, an FDA-cleared wearable ankle robot for gait rehabilitation in stroke patients with foot drop.
ABLE Human Motion
Barcelona medical-device startup founded 2018; CE-marked ABLE Exoskeleton for neurorehabilitation gait therapy, used by 500+ patients in Europe.
Learning Robots
Learning Robots is a Paris-Saclay CNRS spin-off making AlphAI, an educational robot and software for teaching artificial intelligence.
Positronic Robotics
Robotics startup building an open-source Python stack and AI control systems to turn commercial robots into autonomous cleaners.
Opentrons Labworks Inc.
Long Island City, New York lab-automation company founded in 2014; builds the OT-2 and Opentrons Flex liquid-handling robots for life-science research labs.
UnionStrong (Beijing) Technology Co., Ltd. 强联智创(北京)科技股份有限公司
Beijing medical AI firm founded 2016; develops UKnow surgical planning software and a miniaturized robot for intracranial aneurysm treatment.
Aqua Satellite
Mountain View, California underwater-vehicle startup founded 2020 by Alan Eustace; builds AUVs rated to 500 meters with 4K, AI-assisted imaging.
ViscoTec America Inc.
ViscoTec America (Kennesaw, GA) is the US subsidiary of German dosing specialist ViscoTec (est. 1997), making precision dispensing systems for e-mobility.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.